新生儿期Galen静脉动脉瘤样畸形的结局:单中心15年回顾性队列研究
该研究回顾性分析了澳大利亚墨尔本皇家儿童医院四級NICU在2001至2015年间收治的24例新生儿期Galen静脉动脉瘤样畸形(VGAM)患儿的急性期治疗与长期神经发育结局。结果显示15例患儿在NICU住院期间死亡,10例未接受血管内干预;9例存活患儿中仅1例神经发育结局正常。结论认为新生儿期VGAM死亡率高,存活者正常神经发育结局率低。
要点
- 新生儿期VGAM死亡率为15/24,其中10例未接受血管内干预。
- 存活9例中仅1例神经发育结局正常。
- 存活者需在婴儿期后继续接受临床神经发育随访。
核心结论
- 新生儿期VGAM的死亡率高,存活者中正常神经发育结局的比例低。
- 这些发现有助于理解哪些新生儿应接受治疗,并强调对存活者提供超越婴儿期的临床神经发育随访的重要性。
研究设计与样本
- 研究为2001年至2015年共15年的回顾性队列研究。
- 设置于澳大利亚墨尔本皇家儿童医院的四級NICU。
- 纳入24例因VGAM转诊管理的新生儿,未设资格标准,所有就诊婴儿均纳入。
- 无干预措施。
主要发现
- 15例新生儿期VGAM患儿未存活至NICU出院,其中10例未提供血管内干预。
- 9例存活婴儿中,仅1例神经发育结局正常。
- 临床神经影像学数据被收集;存活儿童由神经心理学家和职业治疗师/物理治疗师在儿童早期至中期进行正式评估。
临床怎么用
- 临床医生应认识到新生儿期VGAM的高死亡风险和存活者低正常神经发育结局率。
- 对于存活者,应提供超越婴儿期的临床神经发育随访。
局限性
- 研究为单中心回顾性队列,样本量24例,未设 eligibility criteria,所有就诊婴儿均纳入。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vein of Galenaneurysmal malformation (VGAM) is a rare but important congenital malformation presenting to neonatal intensive care units (NICUs), and with a change from surgical to endovascular management, survival for this condition has improved. However, there is little reported about the medical management decisions of infants with this condition and the associated long-term neurodevelopmental outcomes. We aim to report a single centre experience of both acute treatment and long-term outcomes of VGAM for those infants admitted to our NICU soon after birth. DESIGN: Retrospective cohort study over a 15-year period from 2001 to 2015 inclusive. SETTING: A quaternary NICU at The Royal Children's Hospital, Melbourne, Australia. PARTICIPANTS: 24 newborn infants referred for management of VGAM. There were no eligibility criteria set for this study; all presenting infants were included. INTERVENTIONS: None. MAIN OUTCOMES MEASURES: Clinical neuroimaging data were gathered. Surviving children were formally assessed with a battery of tests administered by a neuropsychologist and occupational therapist/physiotherapist at various ages across early to middle childhood. RESULTS: Fifteen neonates with VGAM did not survive beyond their NICU admission. 10 of these were not offered endovascular intervention. Of the nine surviving infants, only one had a normal neurodevelopmental outcome. CONCLUSIONS: The mortality of VGAM presenting in the neonatal period was high, and rates of normal neurodevelopmental outcome for survivors were low. These findings contribute to our understanding of which neonates should be treated and highlights the importance of providing clinical neurodevelopmental follow-up to survivors beyond their infant years.
引用
- Malarbi S, Gunn-Charlton JK, Burnett AC, et al. Outcome of vein of Galen malformation presenting in the neonatal period. Arch Dis Child. 2019. PMID: 31122925. doi:10.1136/archdischild-2018-316495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。